Sirona Biochem Corp V.SBM

Now a profitable company!?

[forhandlaren]

Not long ago to monthly burn rate was 200.000 CAD/month, let's say 250.000 for arguments sake, which add up to 3 million CAD annually.

For each kilo TFC-1067 sold to R+F they get 8.000 USD which translates to 10.000 CAD. Let's assume that it's sold by R+F as previously communicated, representing 10.000 tubes.

Break even (not including Sirona production costs) is then 300 kg aka 3 million tubes sold annually.

Based on how the customers reacted to the launch I think it's safe to say that Sirona from now on should be proftable.

Other sources to revenue near term is payment related to SGLT2 for pets deal that should be due any day/week now as well as an deal for TFC-1067 with the stronger concentration.

[lscfa]

Despite the poorly worded NR about business model I think the co. will still try to do a licensing deal for 0.4% and not just make and sell it as an ingredient. An exclusive global license may see $10 million upfront payment which will allow co. to accelearate development of other things like the anti-aging drug. "With this launch, we have proven that we can take a compound from the

[MirrorWorldMan]

In the NR, Howie said he was going to do everything exactly the same for all the molecules. So that is against changing their business model away from a manufacturer/supplier of Cosmetics ingredients. Also, the carbo based manufacturing process is proprietary and I would hesitate to think they would let someone else license the reaction mechanism to make it. Finally, the SGLT2 is a different story